Cadila Healthcare has reported results for the fourth quarter and year ended March 31, 2020.
The company has reported 2 - fold jumps in its net profit of Rs 619.30 crore for the quarter under review as compared to Rs 242.20 crore for the same quarter in the previous year. Total income of the company increased by 37.74% at Rs 2212.40 crore for Q4FY20 as compared Rs 1606.20 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 14.82% fall in its net profit of Rs 391.90 crore for the quarter under review as against Rs 460.10 crore for the same quarter in the previous year. However, total income of the company increased by 0.67% at Rs 3796.40 crore for Q4FY20 as compared Rs 3771.20 crore for the corresponding quarter previous year.
For the year ended March 31, 2020, the company has reported a 4.90% fall in its net profit of Rs 1412.90 crore as compared to Rs 1485.70 crore for the previous year. However, total income of the company increased by 9.10% at Rs 7196.80 crore for year under review as compared to Rs 6596.70 crore for year ended March 31, 2019.
For the year ended March 31, 2020, on the consolidated basis, the company has reported a 36.36% fall in its net profit of Rs 1176.60 crore as compared to Rs 1848.80 crore for the previous year. However, total income of the company increased by 7.48% at Rs 14367.00 crore for year under review as compared to Rs 13366.70 crore for year ended March 31, 2019.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: